As on 06 Jun 2025

Tata India Pharma & Healthcare Fund-Direct Plan-Growth
EquityNAV
₹ 34.31
CAGR (3 Years)
25.52%
AUM (Cr)
₹ 1,222.72
Risk
Very High Risk
About Tata India Pharma & Healthcare Fund-Direct Plan-Growth
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
Breakdown of this Fund
Chemicals
0.58%
Debt Others
10.79%
Fertilizers
2.09%
Healthcare
52.62%
Insurance
1.61%
IT - Software
1.04%
Miscellaneous
1.54%
Pharmaceuticals
99.04%
Retail
1.54%
Market Capitalization
Expense Ratio, Exit Load and Tax
Expense Ratio
0.1
Exit Load
0.50% - If redeemed\switched out within 30 days from the date of allotment. Nil ...
Stamp Duty
0.005% (from July 1st, 2020)
Tax Implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.